Cargando…
Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia
BACKGROUND: Post-herpetic neuralgia (PHN) is the most common and most debilitating complication of herpes zoster, and involves considerable associated costs. OBJECTIVE: This paper presents results from nine health economic studies undertaken in eight European countries that compared lidocaine medica...
Autores principales: | Liedgens, Hiltrud, Obradovic, Marko, Nuijten, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3848379/ https://www.ncbi.nlm.nih.gov/pubmed/24348056 http://dx.doi.org/10.2147/CEOR.S51776 |
Ejemplares similares
-
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
por: Bursi, Roberta, et al.
Publicado: (2017) -
Post-herpetic neuralgia
por: Tontodonati, Monica, et al.
Publicado: (2012) -
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
por: Navez, Marie Louise, et al.
Publicado: (2015) -
Validity and responsiveness of EuroQol-5 dimension (EQ-5D) versus Short Form-6 dimension (SF-6D) questionnaire in chronic pain
por: Obradovic, Marko, et al.
Publicado: (2013) -
Reduction of painful area as new possible therapeutic target in post-herpetic neuropathic pain treated with 5% lidocaine medicated plaster: a case series
por: Casale, Roberto, et al.
Publicado: (2014)